Skip to main content
Clinical Trials/ISRCTN36251388
ISRCTN36251388
Active, not recruiting
未知

Modifiable factors for somatic symptom persistence in patients with somatic symptom disorder

niversity Medical Center Hamburg-Eppendorf0 sites240 target enrollmentFebruary 15, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Medical Center Hamburg-Eppendorf
Enrollment
240
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2022
End Date
September 30, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity Medical Center Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinical diagnosis of SSD
  • 2\. Sufficient oral and written German language proficiency
  • 3\. Provision of written informed consent

Exclusion Criteria

  • 1\. Acute serious somatic and/or psychological illness requiring immediate intervention
  • 2\. Florid psychosis
  • 3\. Substance abuse disorder
  • 4\. Acute suicidality
  • 5\. Severe cognitive impairment affecting self\-report questionnaires and interviews

Outcomes

Primary Outcomes

Not specified

Similar Trials